The relationship between the apparent diffusion coefficient and the Ki-67 proliferation index in intracranial solitary fibrous tumor/hemangiopericytoma
- PMID: 34761325
- DOI: 10.1007/s10143-021-01687-y
The relationship between the apparent diffusion coefficient and the Ki-67 proliferation index in intracranial solitary fibrous tumor/hemangiopericytoma
Abstract
This study evaluated the value of the apparent diffusion coefficient (ADC) in distinguishing grade II and III intracranial solitary fibrous tumors/hemangiopericytomas and explored the correlation between ADC and Ki-67. The preoperative MRIs of 37 patients treated for solitary fibrous tumor/hemangiopericytoma (grade II, n = 15 and grade III, n = 22) in our hospital from 2011 to October 2020 were retrospectively analyzed. We compared the difference between the minimum, average, maximum, and relative ADCs based on tumor grade and examined the correlation between ADC and Ki-67. Receiver operating characteristic curve analysis was used to analyze the diagnostic efficiency of the ADC. There were significant differences in the average, minimum, and relative ADCs between grade II and III patients. The optimal cutoff value for the relative ADC value to differentiate grade II and III tumors was 0.998, which yielded an area under the curve of 0.879. The Ki-67 proliferation indexes of grade II and III tumors were significantly different, and the average (r = - 0.427), minimum (r = - 0.356), and relative (r = - 0.529) ADCs were significantly negatively correlated with the Ki-67 proliferation index. ADC can be used to differentiate grade II and III intracranial solitary fibrous tumors/hemangiopericytomas. Our results can be used to formulate a personalized surgical treatment plan before surgery.
Keywords: Apparent diffusion coefficient; Intracranial; Ki-67 proliferation index; MRI; Solitary fibrous tumor/hemangiopericytoma.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Apparent diffusion coefficient histogram analysis to preoperative evaluate intracranial solitary fibrous tumor: Relationship to Ki-67 proliferation index.Clin Neurol Neurosurg. 2022 Sep;220:107364. doi: 10.1016/j.clineuro.2022.107364. Epub 2022 Jul 12. Clin Neurol Neurosurg. 2022. PMID: 35872434
-
Apparent diffusion coefficient values in differential diagnosis and prognostic prediction of solitary of fibrous tumor/hemangiopericytoma (WHOII) and atypical meningioma.Technol Health Care. 2019;27(2):137-147. doi: 10.3233/THC-181447. Technol Health Care. 2019. PMID: 30664513
-
Differentiation of intracranial solitary fibrous tumor/hemangiopericytoma from atypical meningioma using apparent diffusion coefficient histogram analysis.Neurosurg Rev. 2022 Jun;45(3):2449-2456. doi: 10.1007/s10143-022-01771-x. Epub 2022 Mar 18. Neurosurg Rev. 2022. PMID: 35303202
-
A review of solitary fibrous tumor/hemangiopericytoma tumor and a comparison of risk factors for recurrence, metastases, and death among patients with spinal and intracranial tumors.Neurosurg Rev. 2021 Jun;44(3):1299-1312. doi: 10.1007/s10143-020-01335-x. Epub 2020 Jun 18. Neurosurg Rev. 2021. PMID: 32556679
-
Malignant Progression of a Superior Cerebellar Tentorium Solitary Fibrous Tumor in the Pineal Region with Intracranial Metastases: A Case Report and a Literature Review.Curr Med Imaging. 2023;19(11):1351-1359. doi: 10.2174/1573405619666221124104754. Curr Med Imaging. 2023. PMID: 36424770 Review.
Cited by
-
Risk factors for recurrent disease after resection of solitary fibrous tumor: a systematic review.Front Surg. 2024 Jan 31;11:1332421. doi: 10.3389/fsurg.2024.1332421. eCollection 2024. Front Surg. 2024. PMID: 38357190 Free PMC article. Review.
-
Apparent diffusion coefficient values effectively predict cell proliferation and determine oligodendroglioma grade.Neurosurg Rev. 2023 Apr 6;46(1):83. doi: 10.1007/s10143-023-01989-3. Neurosurg Rev. 2023. PMID: 37022533
References
-
- Chmielecki J, Crago A, Rosenberg M et al (2013) Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 45:131–132. https://doi.org/10.1038/ng.2522 - DOI - PubMed - PMC
-
- Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1 - DOI - PubMed
-
- Melone AG, D’Elia A, Santoro F, Salvati M, Delfini R, Cantore G et al (2014) Intracranial hemangiopericytoma–our experience in 30 years: a series of 43 cases and review of the literature. World Neurosurg 81(3–4):556–562. https://doi.org/10.1016/j.wneu.2013.11.009 - DOI - PubMed
-
- Ratneswaren T, Hogg FRA, Gallagher MJ, Ashkan K (2018) Surveillance for metastatic hemangiopericytoma-solitary fibrous tumors-systematic literature review on incidence, predictors and diagnosis of extra-cranial disease. J Neurooncol 138(3):447–467. https://doi.org/10.1007/s11060-018-2836-2 - DOI - PubMed
-
- Rutkowski MJ, Jian BJ, Bloch O, Chen C, Sughrue ME, Tihan T et al (2012) Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients. Cancer 118(6):1628–1636. https://doi.org/10.1002/cncr.26411 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources